HBM Healthcare Investments
Fund of fundsLate Stage · 5 people tracked
Investment thesis
HBM Healthcare Investments targets the global healthcare market, which benefits from demographic trends including population growth and aging, medical innovation, rising prosperity particularly in emerging markets, and improved access to medical products and services. The firm focuses on capturing value from sustained innovation across healthcare products, services, and business models addressing an expanding range of disease indications.
Source: firm website, verified Jul 21, 2026.
Team · 5 people
from the firm's websiteWhat they invest in
from 1 of 1 portfolio companiesBiotech ×1Healthtech ×1Medical Devices ×1
Investments · 1 tracked
founders shown can be your intro pathDren Bio is a clinical-stage biopharmaceutical company developing novel antibody therapeutics designed to selectively eliminate pathogenic cells and disease-causing agents, with a pipeline targeting oncology, autoimmune diseases, immunology, and neurology.
BiotechHealthtechMedical Devices
Frequently asked questions
- What stage does HBM Healthcare Investments invest at?
- HBM Healthcare Investments invests at the Late Stage stage.
- What sectors does HBM Healthcare Investments focus on?
- HBM Healthcare Investments focuses on Biotech, Digital Health, Healthtech, Longevity, Medical Devices.
Similar investors
A venture capital firm focused on investing in companies developing technologies at the intersection of human performance, AI, and advanced biology. The portfolio spans digital therapeutics, neuroscience, AI-driven healthcare, robotics, and biological innovation.
A globally recognized venture capital firm designed to provide access to highly competitive venture deals to individual investors, consistently recognized for top-decile DPI performance and as one of the most active US venture firms.
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
GV is Alphabet's venture capital arm, established in 2009 as Google Ventures. Operating with long time horizons and over $13 billion in assets under management, the firm invests across technology and life sciences sectors from seed to growth stages, supporting 400 active portfolio companies across North America, Europe, and Israel.